Skip to content

Screener

Eligibility screening

Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hi…

Sponsored by AbbVieStudy detailsClinicalTrials.gov

87 US sites in AL, AR, AZ, CA +24

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.